Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. financial statements

Lyell Immunopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 36K10-K
Net income−USD 274.45M10-K
Cash and equivalentsUSD 60.18M10-Q
Total debtUSD 50.99MEODHD

Lyell Immunopharma, Inc. financials on 6ix · Lyell Immunopharma, Inc. on 6ix